The crypto industry has taken a sharp turn back towards privacy — and it can now exist side by side with regulatory ...

I want to be clear about who I am writing to. Roughly a year ago, 77,302,580 Americans voted for Donald J. Trump to be the President of the United States. Some portion of that number — I cannot be ...

Argentina's President Javier Milei concluded his mid-term election campaign on Thursday with a promise for change as a persistent financial crisis weighs on the country. The legislative elections will ...

Rapt Therapeutics said a mid-stage trial of its drug for chronic spontaneous urticaria, a skin condition that causes recurrent, spontaneous hives, showed comparable efficacy and safety to omalizumab, ...

After years of government antipathy toward the U.S. under the Movement Toward Socialism party, Paz pledged to rebuild relations with Washington — and attract foreign investment to a country long ...

President Donald Trump on Thursday announced a deal with EMD Serono, a subsidiary of German drugmaker Merck KGaA XE:MRK MKKGY, that aims to cut the out-of-pocket costs for in vitro fertilization, with ...

Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation.

Gnoppix is a Linux distribution that is free to install and use. Gnoppix runs smoothly, offers tons of apps, and is user-friendly. The gnoppix-ai package seems to be broken, so I'd avoid it. I've used ...

Travis Gettys is a senior editor for Raw Story based in northern Kentucky. He previously worked as a web editor for WLWT-TV and a contributing writer for the Kentucky Enquirer, and he also wrote for ...

JACKSONVILLE, Fla. — Renters at two eastside apartment complexes say a local non-profit left them with broken promises after it stepped in back in 2023 to improve living conditions at the properties, ...

*A recent clinical trial suggests that a new experimental cannabis-based drug can ease chronic lower-back pain. German drugmaker Vertanical conducted an 800-patient trial that showcased its low-THC ...